QHSLab Inc. Engages Hayden IR for Investor Relations Initiative

West Palm Beach, FL – QHSLab Inc. (OTCQB: USAQ), a digital health company that provides point-of-care diagnostic tools and digital healthcare solutions, announced on February 26, 2025, that it has retained Hayden IR, a nationally recognized investor relations firm, to enhance its visibility and strengthen engagement with the investment community.

In a press release issued on the same day, QHSLab highlighted its recent advancements in expanding its suite of digital health solutions, growing its provider network, and solidifying its market presence. The company affirmed that engaging Hayden IR is a strategic move to reach a broader investor audience and more effectively communicate its business strategy and ongoing achievements.

Hayden IR, which operates from offices in New York, Phoenix, and Dallas, brings over two decades of experience in investor relations to a growing roster of micro- and small-cap companies. The firm specializes in investor management, awareness campaigns, and building corporate identity, areas that are expected to support QHSLab’s efforts as it continues to innovate and expand within the digital health and primary care diagnostic sectors.

Troy Grogan, President and CEO of QHSLab, stated that the engagement with Hayden IR comes as the company continues to drive innovation and scale its operations, positioning it to capitalize on significant market opportunities in digital health. Hayden IR’s Managing Principal, Brett Maas, noted that QHSLab’s portfolio of healthcare solutions and data-driven strategy positions the company well for growth in the competitive primary care diagnostics market.

The filing, made via Form 8-K with the Securities and Exchange Commission, also includes standard forward-looking statements with reference to potential risks and uncertainties that could affect future outcomes. QHSLab underscored that any updates or changes to these forward-looking statements will not be publicly disseminated unless expressly required.

This strategic initiative marks a key step for QHSLab as it seeks to further solidify its investor relations and strengthen its market position in the rapidly evolving digital healthcare landscape.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read QHSLab’s 8K filing here.

About QHSLab

QHSLab, Inc, a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine.